Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bei Yan

Showing results (231-240 of 235) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 235 results.
Therapeutic Advances in Medical Oncology|May 11, 2026
CD71 as an independent prognostic factor in pediatric B-ALL: a regional multicenter retrospective study in Southern China (SCCLG-ALL-2016)Xing-Fei Chen, Wen-Guang Jia, Ying Liu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 23, 2021
Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trialJia Liu, Wei Yang, Yue Liu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 1, 2020
Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trialNannan Shi, Lanping Guo, Bin Liu, et al.
Frontiers in Oncology|January 6, 2022
Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children's Leukemia GroupKun-Yin Qiu, Hong-Gui Xu, Xue-Qun Luo, et al.
Frontiers in Medicine|October 4, 2021
Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical TrialChen Zhao, Li Li, Wei Yang, et al.
Pageof 24

Showing results (231-240 of 235) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 235 results.
Therapeutic Advances in Medical Oncology|May 11, 2026
CD71 as an independent prognostic factor in pediatric B-ALL: a regional multicenter retrospective study in Southern China (SCCLG-ALL-2016)Xing-Fei Chen, Wen-Guang Jia, Ying Liu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 23, 2021
Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trialJia Liu, Wei Yang, Yue Liu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 1, 2020
Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trialNannan Shi, Lanping Guo, Bin Liu, et al.
Frontiers in Oncology|January 6, 2022
Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children's Leukemia GroupKun-Yin Qiu, Hong-Gui Xu, Xue-Qun Luo, et al.
Frontiers in Medicine|October 4, 2021
Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical TrialChen Zhao, Li Li, Wei Yang, et al.
Pageof 24